NCT00457782 2024-04-25A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaKyowa Kirin Co., Ltd.Phase 1 Completed27 enrolled